Healthcareassociated Infectious Disease Diagnostics
Market
Healthcare-associated Infectious Disease
Diagnostics Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Healthcare-associated Infectious Disease Diagnostics
Market Size and Growth
The healthcare-associated infectious disease diagnostics market is expanding, driven by rising infection rates and technological advancements. In 2023, the market size is estimated at approximately $4.5 billion, with a projected CAGR of 8% over the next five years. Growing awareness and improved diagnostic tools are key growth factors in this sector. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ Accelerate Diagnostics
◍ BD
◍ bioMrieux
◍ Bio-Rad
◍ DiaSorin Molecular
◍ F. Hoffmann-La Roche
◍ Luminex
◍ Meridian Bioscience
◍ OpGen
◍ QIAGEN
◍ Quidel
◍ Thermo Fisher Scientific
◍ Trinity Biotech
◍ Danaher
The Healthcare-associated Infectious Disease Diagnostics Market features key players like Abbott, BD, and Roche, leveraging innovative technologies and rapid testing solutions. Their advancements enhance diagnosis accuracy, driving market growth. Some revenue figures include Abbott's $43 billion and Thermo Fisher's $40 billion, reflecting their significant contributions to this market.
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Clinics
◍ ASCs
By Product
◍ Urinary Tract Infections
◍ Surgical Site Infections
◍ Hospital-acquired Pneumonia
◍ BloodStream Infections
◍ Gastrointestinal Infections
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
